Traverse sinks teeth into human periodontal study
By GREGORY ZELLER // It seems everyone wants a piece of TRB-N0224. Already being tested as a potential treatment for lung injuries and for periodontal disease in dogs and cats,…
Biotech
Some pig: USDA, Codagenix target swine flu
By GREGORY ZELLER // With Zika virus, Foot and Mouth Disease and other global threats already in its crosshairs, Farmingdale biotech Codagenix Inc. is challenging another high-profile opponent: swine flu….
Traverse, SUNY, DoD set big test for TRB-N0224
Stony Brook-based biotech Traverse Biosciences will share a Department of Defense award with SUNY Upstate Medical University to fund a critical field test of Traverse’s leading drug candidate. The effectiveness…
Study is big news for Vagus pioneer Tracey
By GREGORY ZELLER // Medical science has taken an enormous step toward “using electronics to replace drugs.” Kevin Tracey’s words sound downright science-fictional. And no, researchers cannot wave a medical…
‘Accidental’ find may be COPD breakthrough
By GREGORY ZELLER // From the Didn’t See That Coming File comes Stony Brook University researcher Ute Moll and the p73 gene – potentially, a master key to unlocking new…
Traverse Biosciences lands key seed investment
By GREGORY ZELLER // A critical seed investment will help Traverse Biosciences commercialize pharmaceutical candidates licensed from the SUNY Research Foundation. The circa-2013 Stony Brook-based biotech has secured $500,000 in…
Novel Parkinson’s Procedure Pumps Up NSUH
By GREGORY ZELLER // They’re dancing in the aisles, literally, at North Shore University Hospital, thanks to a revolutionary treatment for Parkinson’s disease. Surgeons at the Manhasset hospital, part of…
Applied DNA Taking it to Swedish car thieves
By GREGORY ZELLER // Let this be a warning to Swedish car thieves: Applied DNA Sciences is on the case. Through Safesolutions AB (bring your Swedish or try the Google…
Feinstein’s Tracey to head bioelectronics summit
Feinstein Institute chief and global bioelectronics pioneer Kevin Tracey will headline a September New York Academy of Science conference on bioelectronic medicine. Tracey, Feinstein’s president and CEO and the brains…
TheraSource snags $3M SBIR grant
By GREGORY ZELLER // A Feinstein Institute-born biotech will tackle radiation poisoning thanks to a grant from the National Institute of Allergy and Infectious Diseases. TheraSource, a Manhasset-based 2004 startup…
Applied DNA inks $2.5M federal contract
By GREGORY ZELLER // Biotech firm Applied DNA Sciences has announced a new $2.5 million contract with “a U.S. government agency” covering the use of its flagship SigNature DNA security…
Feinstein joins the LI Bioscience Hub
By GREGORY ZELLER // The Feinstein Institute for Medical Research has joined the ranks of the Long Island Bioscience Hub. The Feinstein Institute, the research wing of the Northwell Health…
The people have spoken: It’s 3D-printed tissue
With nearly half-a-million votes cast, Northwell Health is ready to declare a 3D bioprinting project the winner of its $100,000 Medical Innovation Contest. The month-long multimedia contest, featuring television commercials…
Andrew Whiteley is now executively in residence
By GREGORY ZELLER // It’s become vogue for research institutions to staff “entrepreneurs-in-residence,” experienced innovators who can help science-based startups find their commercial footing, because they’ve been there and done…
Patent Board rejects challenge to CSHL research
By GREGORY ZELLER // A big win before the U.S. Patent Trial and Appeal Board will keep a versatile biomedical-research and drug-discovery tool in Cold Spring Harbor Laboratory’s possession. The…